tiprankstipranks
I-Mab Reports Full Year 2023 Financial Results and Business Update
PremiumPress ReleasesI-Mab Reports Full Year 2023 Financial Results and Business Update
1M ago
I-Mab to divest assets, business operations in China fo $80M
PremiumThe Fly
I-Mab to divest assets, business operations in China fo $80M
2M ago
I-Mab granted FDA Breakthrough Therapy Designation for felzartamab
PremiumThe Fly
I-Mab granted FDA Breakthrough Therapy Designation for felzartamab
6M ago
I-Mab price target lowered to $23 from $24 at Needham
PremiumThe FlyI-Mab price target lowered to $23 from $24 at Needham
7M ago
I-Mab price target lowered to $18 from $25 at H.C. Wainwright
PremiumThe Fly
I-Mab price target lowered to $18 from $25 at H.C. Wainwright
8M ago
I-Mab Provides Mid-Year 2023 Financial Results, Business and Corporate Updates
PremiumPress Releases
I-Mab Provides Mid-Year 2023 Financial Results, Business and Corporate Updates
8M ago
Tracon announces $23M arbitration award in dispute with I-Mab
PremiumThe FlyTracon announces $23M arbitration award in dispute with I-Mab
12M ago
I-Mab receives arbitration award relating to Tracon CD73 antibody pact
PremiumThe Fly
I-Mab receives arbitration award relating to Tracon CD73 antibody pact
12M ago
I-Mab doses first patient in Phase 3 study of lemzoparlimab in MDS in China
PremiumThe Fly
I-Mab doses first patient in Phase 3 study of lemzoparlimab in MDS in China
12M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100